Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis-Reference-Cited by-同舟云学术

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

Published:2017-09-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jairath Vipul¹²³,Zou GY²³,Parker Claire E²,MacDonald John K¹⁴,AlAmeel Turki⁵,Al Beshir Mohammad⁵,Almadi Majid A⁶⁷,Al-Taweel Talal⁸,Atkinson Nathan SS⁹,Biswas Sujata¹⁰,Chapman Thomas¹¹,Dulai Parambir S¹²,Glaire Mark A¹³,Hoekman Daniël R¹⁴,Koutsoumpas Andreas⁹,Minas Elizabeth¹⁵,Mosli Mahmoud H¹⁶,Samaan Mark¹⁴,Khanna Reena¹²,Travis Simon¹⁷,D'Haens Geert¹⁴¹⁸,Sandborn William J¹⁹²⁰,Feagan Brian G¹²³⁴

Affiliation:

1. University of Western Ontario; Department of Medicine; London ON Canada

2. Robarts Clinical Trials; London ON Canada

3. University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada

4. Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

5. King Fahad Specialist Hospital-Dammam; Department of Medicine; P.O Box 15215 Dammam Saudi Arabia 31444

6. King Khalid University Hospital; Division of Gastroenterology; Riyadh Saudi Arabia

7. King Saud University; Riyadh Saudi Arabia

8. Mubarak Al-Kabeer Hospital; Jabriyah Kuwait

9. John Radcliffe Hospital; Gastroenterology Unit; Headley Way Oxford UK OX3 9DU

10. Wellcome Trust Centre for Human Genetics; Translational Gastroenterology Unit; Roosevelt Drive Oxford UK OX3 7BN

11. John Radcliffe Hospital; Translational Gastroenterology Unit; Headley Way Oxford UK OX3 9DU

12. University of California San Diego; La Jolla CA USA

13. John Radcliffe Hospital; Oxford UK OX3 9DU

14. Academic Medical Center; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

15. Wexham Park Hospital; Wexham Slough Berkshire UK

16. King Abdulaziz University; King Abdulaziz University Hospital; Jeddah Saudi Arabia

17. University of Oxford; Translational Gastroenterology Unit, Nuffield Department of Medicine; Oxford UK

18. Robarts Clinical Trials; Amsterdam Netherlands

19. University of California San Diego; Division of Gastroenterology; La Jolla CA USA

20. Robarts Clinical Trials; San Diego CA USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference267 articles.

1. Twice-daily budesonide rectal foam induces complete mucosal healing in Japanese patients with mild to moderate ulcerative colitis: Results of multicenter, randomized, double-blind, placebo-controlled trial;Aoyama;Journal of Crohn's and Colitis,2015

2. Controlled trial of 4-ASA in ulcerative colitis;Beeken;Digestive Diseases and Sciences,1997

3. Methotrexate for corticosteroid-dependent ulcerative colitis: Results of a placebo randomized controlled trial;Carbonnel;Gastroenterology,2016

4. Methotrexate for corticosteroid-dependent ulcerative colitis: Results of a placebo randomized controlled trial;Carbonnel;Journal of Crohn's and Colitis,2015

5. Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a large proportion of patients with ulcerative colitis;Carbonnel;Gastroenterology,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes;Inflammatory Bowel Diseases;2024-08-23

2. A Multi-Center Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin Rich Extract (ACRE) in Patients with Ulcerative Colitis;2024-07-21

3. Consistent efficacy outcomes between phase 2 and phase 3 trials in Crohn’s disease or ulcerative colitis in adults: a meta-analysis;Inflammation Research;2024-04-08

4. A review on the use of prebiotics in ulcerative colitis;Trends in Microbiology;2023-12

5. Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study;Inflammatory Bowel Diseases;2023-07-21